Skip to main content
. 2016 Apr 21;6:24765. doi: 10.1038/srep24765

Table 3. Segregation patterns of CRISPR/Cas9-medicated targeted mutagenesis during the T0 to T1 generation.

Target gene sgRNA Line# T0
T1
Zygosity$ Genotype Mutation segregation T-DNA
SlPIF4 1 T0-22 Homozygote d1d1 15d1d1 12+;3−
SlPIF4 2 T0-19 Homozygote d1d1 14d1d1 10+:4−
SlPIF4 2 T0-8 Biallele d2,d9 3d2d2,6e*,5d9d9 10+:4−
SlPIF4 2 T0-10 Biallele d3,i1 1d3d3,7e,5i1i1 8+:5−
SlPDS 1 T0-20 Chimera d5,d12,c102,WT 8e 5+;1−
SlPIF4 1 T0-3 Chimera d3,d4,i1 13e,2i1 11+:4−
SlPIF4 2 T0-12 Chimera d2,d6,d17,c7 5d6,2e,5d2 All+
SlPIF4 2 T0-16 Chimera d1,d2,d3 8d2,11e,3d1 14+:8−
SlPIF4 1 T0-6 WT WT 13WT 12+:1−
SlPDS 1 T0-18 WT WT 16WT 9+:7−

#Line name is in the format of T0-#.

$The zygosoty of homozygote, biallele and chimera in T0 plant lines were putative. d#, # of bp deleted at the target sites; i#, # number of bases insertion at target sites; c#, combined mutation; WT, wild-type sequence without mutations detected at target sites.

*e, heterogeneous, more than one sequence detected in the sample; +, T-DNA was detected; −, T-DNA was not detected.

HHS Vulnerability Disclosure